Inhaled bispecific single-domain antibody BM219 for mild-to-moderate COVID-19: a double-blind, randomized, placebo-controlled phase 2 trial.
作者信息
Wu Yanling, Li Yuan, Zhang Ping, Guo Siwei, Yuan Fang, Liu Vivian, Yu Ting, Lin Feng, Yang Nan, Tu Chao, Lu Hongzhou, Ying Tianlei, Li Xin
机构信息
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Department of Pulmonary and Critical Care Medicine, Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Pharmacy, The Third Hospital of Changsha, Changsha, Hunan, China.
出版信息
Cell Discov. 2025 Jul 17;11(1):64. doi: 10.1038/s41421-025-00813-0.
Abstract
摘要
Zotero 插件